Summary Case 9: Splanchnic vein thrombosis as the initial manifestation of polycythemia vera in a 26-year-old woman;Fall 9: Eine 26jährige Frau mit splanchnischer Venenthrombose als Initialmanifestation einer Polycythaemia vera

Therapeutische Umschau

Volumn 56, Issue 9, 1999, Pages 505-508

  Escher, Robert ^a   Demarmels Biasiutti, F ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; BLOOD; BLOOD CLOTTING TEST; CASE REPORT; CESAREAN SECTION; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HETEROZYGOTE DETECTION; HUMAN; POINT MUTATION; POLYCYTHEMIA VERA; PORTAL VEIN; POSTOPERATIVE COMPLICATION; THROMBOPHILIA; THROMBOSIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; BLOOD COAGULATION TESTS; CESAREAN SECTION; DIAGNOSIS, DIFFERENTIAL; FACTOR V; FEMALE; HETEROZYGOTE DETECTION; HUMANS; POINT MUTATION; POLYCYTHEMIA VERA; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; THROMBOPHILIA; THROMBOSIS;

EID: 0033193502     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.56.9.505     Document Type: Article

References (13)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90:1004.
2. Willoughby S, Pearson TC. The use of aspirin in polycythaemia vera and primary thrombocythaemia. Blood Rev 1998;12:12.
3. Kupfermine MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9.
4. Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, Paciaroni K, Leone G, Faioni EM. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998;92:2353.
5. Borgel D, Gandrille S, Aiach M. Protein S deficiency. Thromb Haemost. 1997;78:351.
6. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet. 1993;342:1503.
7. McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, Carty MJ, Greer IA. Risk factor for pregnancy associated venous thromboembolism. Thromb Haemost. 1997;78:1183.
8. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol. 1995;90:725.
9. Demarmels Biasiutti F, Sulzer I, Stucki B, Wuillemin WA, Furlan M, Lämmle B. Is plasminogen deficiency a thrombotic risk factor? - A study on 23 thrombophilic patients and their family members. Thromb Haemost. 1998;80: 167.
10. Koeleman BP, Reitsma PH, Bertina RM. Familial thrombophilia: a complex genetic disorder. Semin Hematol 1997;34:256.
11. Boughton BJ. Hepatic and portal vein thrombosis. BrMedJ. 1991;302:192.
12. De Stefano V, Teofili L, Leone G, Michiels JJ. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997;23:411.
13. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531.